Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In the latest session, CorMedix Inc (NASDAQ: CRMD) closed at $9.99 down -0.65% from its previous closing price of $10.06. In other words, the price has decreased by -$0.65 from its previous closing price. On the day, 1.56 million shares were traded. CRMD stock price reached its highest trading level at $10.53 during the session, while it also had its lowest trading level at $9.79.
Ratios:
For a deeper understanding of CorMedix Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.60 and its Current Ratio is at 3.96. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Rodman & Renshaw on August 26, 2024, initiated with a Buy rating and assigned the stock a target price of $13.
On August 10, 2023, RBC Capital Mkts started tracking the stock assigning a Outperform rating and target price of $6.
On February 17, 2021, Needham started tracking the stock assigning a Buy rating and target price of $31.Needham initiated its Buy rating on February 17, 2021, with a $31 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Mar 13 ’24 when Todisco Joseph bought 13,561 shares for $3.74 per share. The transaction valued at 50,718 led to the insider holds 352,839 shares of the business.
DUNTON ALAN W bought 3,000 shares of CRMD for $10,350 on Dec 14 ’23. The Director now owns 12,250 shares after completing the transaction at $3.45 per share. On Dec 15 ’23, another insider, DUNTON ALAN W, who serves as the Director of the company, bought 3,000 shares for $3.30 each. As a result, the insider paid 9,900 and bolstered with 15,250 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CRMD now has a Market Capitalization of 606165184 and an Enterprise Value of 560692160. For the stock, the TTM Price-to-Sale (P/S) ratio is 49.12 while its Price-to-Book (P/B) ratio in mrq is 9.85. Its current Enterprise Value per Revenue stands at 45.725 whereas that against EBITDA is -11.045.
Stock Price History:
Over the past 52 weeks, CRMD has reached a high of $13.85, while it has fallen to a 52-week low of $2.57. The 50-Day Moving Average of the stock is 17.01%, while the 200-Day Moving Average is calculated to be 83.64%.
Shares Statistics:
For the past three months, CRMD has traded an average of 1.07M shares per day and 2082540 over the past ten days. A total of 60.68M shares are outstanding, with a floating share count of 59.73M. Insiders hold about 1.56% of the company’s shares, while institutions hold 30.62% stake in the company. Shares short for CRMD as of 1728950400 were 7860576 with a Short Ratio of 7.34, compared to 1726185600 on 10381716. Therefore, it implies a Short% of Shares Outstanding of 7860576 and a Short% of Float of 13.59.
